Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Takeda Pharmaceutical Company patents

Patents where

Current Assignee

Name

Takeda Pharmaceutical Company

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11650159 Method of predicting a performance characteristic of a plant or yeast hydrolysate and its use	Patent 11650159 was granted and assigned to Takeda Pharmaceutical Company on May, 2023 by the United States Patent and Trademark Office.	Takeda Pharmaceutical Company	Takeda Pharmaceutical Company	United States Patent and Trademark Office	11650159	May 16, 2023
‌ US Patent 11583563 Adeno-associated virus formulations	Patent 11583563 was granted and assigned to Takeda Pharmaceutical Company on February, 2023 by the United States Patent and Trademark Office.	Takeda Pharmaceutical Company	Takeda Pharmaceutical Company	United States Patent and Trademark Office	11583563	February 21, 2023
‌ US Patent 11684548 Pooling device for single or multiple medical containers	Patent 11684548 was granted and assigned to Takeda Pharmaceutical Company on June, 2023 by the United States Patent and Trademark Office.	Takeda Pharmaceutical Company	Takeda Pharmaceutical Company	United States Patent and Trademark Office	11684548	June 27, 2023
‌ US Patent 8980322 Controlled release composition	Patent 8980322 was granted and assigned to Takeda Pharmaceutical Company on March, 2015 by the United States Patent and Trademark Office.		Takeda Pharmaceutical Company	United States Patent and Trademark Office	8980322	March 17, 2015
‌ US Patent 7431942 Orally disintegrable tablets	Patent 7431942 was granted and assigned to Takeda Pharmaceutical Company on October, 2008 by the United States Patent and Trademark Office.		Takeda Pharmaceutical Company	United States Patent and Trademark Office	7431942	October 7, 2008
‌ US Patent 7314754 Polynucleotide encoding the hOT7T175 G protein coupled receptor	Patent 7314754 was granted and assigned to Takeda Pharmaceutical Company on January, 2008 by the United States Patent and Trademark Office.		Takeda Pharmaceutical Company	United States Patent and Trademark Office	7314754	January 1, 2008
‌ US Patent D953348 Display screen with a transitional graphical user interface	Patent D953348 was granted and assigned to Takeda Pharmaceutical Company on May, 2022 by the United States Patent and Trademark Office.	Takeda Pharmaceutical Company	Takeda Pharmaceutical Company	United States Patent and Trademark Office	D953348	May 31, 2022
‌ US Patent 7034039 Fused heterocyclic compounds	Patent 7034039 was granted and assigned to Takeda Pharmaceutical Company on April, 2006 by the United States Patent and Trademark Office.		Takeda Pharmaceutical Company	United States Patent and Trademark Office	7034039	April 25, 2006
‌ US Patent 7875292 Orally disintegrable tablets	Patent 7875292 was granted and assigned to Takeda Pharmaceutical Company on January, 2011 by the United States Patent and Trademark Office.		Takeda Pharmaceutical Company	United States Patent and Trademark Office	7875292	January 25, 2011
‌ US Patent 7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity	Patent 7179823 was granted and assigned to Takeda Pharmaceutical Company on February, 2007 by the United States Patent and Trademark Office.		Takeda Pharmaceutical Company	United States Patent and Trademark Office	7179823	February 20, 2007
‌ US Patent 11564992 Nucleophilic catalysts for oxime linkage	Patent 11564992 was granted and assigned to Takeda Pharmaceutical Company on January, 2023 by the United States Patent and Trademark Office.	Takeda Pharmaceutical Company	Takeda Pharmaceutical Company	United States Patent and Trademark Office	11564992	January 31, 2023
‌ US Patent 10323026 Heterocyclic compound	Patent 10323026 was granted and assigned to Takeda Pharmaceutical Company on June, 2019 by the United States Patent and Trademark Office.		Takeda Pharmaceutical Company	United States Patent and Trademark Office	10323026	June 18, 2019
‌ US Patent 7410641 Antibodies to insulin/IGF/relaxin family polypeptides	Patent 7410641 was granted and assigned to Takeda Pharmaceutical Company on August, 2008 by the United States Patent and Trademark Office.		Takeda Pharmaceutical Company	United States Patent and Trademark Office	7410641	August 12, 2008
‌ US Patent 11040109 Blood coagulation protein conjugates	Patent 11040109 was granted and assigned to Takeda Pharmaceutical Company on June, 2021 by the United States Patent and Trademark Office.		Takeda Pharmaceutical Company	United States Patent and Trademark Office	11040109	June 22, 2021
‌ US Patent 11421202 Virus filtration of cell culture media	Patent 11421202 was granted and assigned to Takeda Pharmaceutical Company on August, 2022 by the United States Patent and Trademark Office.	Takeda Pharmaceutical Company	Takeda Pharmaceutical Company	United States Patent and Trademark Office	11421202	August 23, 2022
‌ US Patent 9643967 Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors	Patent 9643967 was granted and assigned to Takeda Pharmaceutical Company on May, 2017 by the United States Patent and Trademark Office.	Takeda Pharmaceutical Company	Takeda Pharmaceutical Company	United States Patent and Trademark Office	9643967	May 9, 2017
‌ US Patent D1012092 Display screen with a transitional graphical user interface	Patent D1012092 was granted and assigned to Takeda Pharmaceutical Company on January, 2024 by the United States Patent and Trademark Office.	Takeda Pharmaceutical Company	Takeda Pharmaceutical Company	United States Patent and Trademark Office	D1012092	January 23, 2024
‌ US Patent 9011926 Method for producing granules	Patent 9011926 was granted and assigned to Takeda Pharmaceutical Company on April, 2015 by the United States Patent and Trademark Office.		Takeda Pharmaceutical Company	United States Patent and Trademark Office	9011926	April 21, 2015
‌ US Patent 7960348 Metastin derivatives and use thereof	Patent 7960348 was granted and assigned to Takeda Pharmaceutical Company on June, 2011 by the United States Patent and Trademark Office.		Takeda Pharmaceutical Company	United States Patent and Trademark Office	7960348	June 14, 2011
‌ US Patent 9241910 Orally-disintegrating solid preparation	Patent 9241910 was granted and assigned to Takeda Pharmaceutical Company on January, 2016 by the United States Patent and Trademark Office.		Takeda Pharmaceutical Company	United States Patent and Trademark Office	9241910	January 26, 2016
‌ US Patent 7510728 Solid preparations	Patent 7510728 was granted and assigned to Takeda Pharmaceutical Company on March, 2009 by the United States Patent and Trademark Office.		Takeda Pharmaceutical Company	United States Patent and Trademark Office	7510728	March 31, 2009
‌ US Patent 7625696 Screening method	Patent 7625696 was granted and assigned to Takeda Pharmaceutical Company on December, 2009 by the United States Patent and Trademark Office.		Takeda Pharmaceutical Company	United States Patent and Trademark Office	7625696	December 1, 2009
‌ US Patent 11434304 Anti-CD38 antibodies	Patent 11434304 was granted and assigned to Takeda Pharmaceutical Company on September, 2022 by the United States Patent and Trademark Office.	Takeda Pharmaceutical Company	Takeda Pharmaceutical Company	United States Patent and Trademark Office	11434304	September 6, 2022
‌ US Patent 7419956 Isolated physiologically active peptide and use thereof	Patent 7419956 was granted and assigned to Takeda Pharmaceutical Company on September, 2008 by the United States Patent and Trademark Office.		Takeda Pharmaceutical Company	United States Patent and Trademark Office	7419956	September 2, 2008
‌ US Patent 6984653 Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof	Patent 6984653 was granted and assigned to Takeda Pharmaceutical Company on January, 2006 by the United States Patent and Trademark Office.		Takeda Pharmaceutical Company	United States Patent and Trademark Office	6984653	January 10, 2006

...

Results per page:

945 results

0 selected

945 results

0 selected